October 2026 Issues of APA Journals feature new research on neuromodulation and precision therapeutics, esketamine, and more

WASHINGTON, D.C., Oct. 1, 2026 — The latest issues of four American Psychiatric Association journals (The American Journal of Psychiatry, Psychiatric Services, American Journal of Psychotherapy, and Psychiatric Research and Clinical Practice) are now available online.

The October issue of The American Journal of Psychiatry brings together experts to guest edit and contribute to a special issue on Neuromodulation and Precision Therapeutics. Guest Editor William McDonald, M.D., professor of psychiatry and behavioral sciences with Emory University School of Medicine, joins Ned Kalin, AJP editor-in-chief, on the AJP Audio podcast this month to discuss the special issue. Highlights of the issue include:

• Brain Stimulation Therapeutic Interventions in Neuropsychiatry: A Cambrian Explosion
• Artificial Intelligence as the Computational Framework for Adaptive Closed-Loop Neuromodulation in Psychiatry
• Bilateral Theta-Burst Stimulation of Dorsolateral Prefrontal Cortex Regions for Late-Life Depression: A Randomized, Sham-Controlled Clinical Trial (AJP Deputy Editor Daniel Pine, M.D., highlights the study in this video.)
• Convergent Network Localization of Brain Stimulation Targets for Trait Anxiety (AJP Deputy Editor Daniel Pine, M.D., highlights the study in this video.)
• The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions (Lead author Charles R. Conway, M.D., joins the  AJP Audio podcast to discuss these findings.)

• Precision Neuromodulation in Psychiatry: Focus on Temporal Interference Stimulation
• Clinical and Cognitive Outcomes Comparing Right Unilateral Ultrabrief Electroconvulsive Therapy Versus Magnetic Seizure Therapy for Bipolar Depression: The CORRECT-BD Trial
• Individualized Connectivity-Guided Versus Conventional Targeting of Accelerated Theta-Burst Stimulation in Depression: A Randomized, Double-Blind, Parallel-Design Trial
• Commentary: Advancing Brain Stimulation to First-Line Psychiatric Therapy: Wearable Disposable Electrotherapy
• Implantable Neuromodulation Devices in Psychiatry: Human Fidelity and Implementation Challenges

Psychiatric Services

•     The Mental Wellness Tool: A Brief Screener for Mental Disorders, Substance Use Disorders, and Suicide Risk

•     Emergency Psychiatric Evaluation of People Under Arrest: Recommendations from a Participatory Policymaking Symposium

•     VA Health Care Utilization Among U.S. Veterans: The Influence of Social Determinants of Health and Health Factors

•     Suicide Surveillance and Simpson’s Paradox: When Aggregation Obscures

•     Wait Time and Documentation Required for Child Psychiatric Care Across Payer and Facility Types

•     Public Support for State Laws Requiring Addiction Programs to Offer FDA-Approved Medications for Opioid Use Disorder.

American Journal of Psychotherapy 

•       Gender and Age Differences in Psychotherapy Use Among U.S. Adults With Depression and Anxiety

•       Effects of Psychotherapies for Posttraumatic Stress Disorder on Anger: An Exploratory Study

•       The RFP-C Triangle of Conflict: Listening to Countertransference Helps Listening to Children With Disruptive Behaviors

•       Interpersonal Psychotherapy in the Chinese Cultural Context: Exploring the Problem Areas With Cultural Specificity

•       Initial Acceptability and Outcomes of Group Acceptance and Commitment Therapy for Adolescent Anxiety

Psychiatric Research and Clinical Practice 

•       Viewpoint: Fostering Social Connection: Progress and Opportunities in VA and Beyond

•       Comparative Risks of Pregnancy Complications in Women Prescribed Psychostimulants or Atomoxetine During Pregnancy Following Pre‐Pregnancy Stimulant Use

•       Real‐World Effectiveness and Cost‐Differential of Intranasal Esketamine Versus Intramuscular Ketamine

•       A Real‐World Pilot of the Collaborative Care Model for Adults With Cognitive Impairment and Neuropsychiatric Symptoms in Primary Care

Journalists who want to access the publications should email press@psych.org.

American Psychiatric Association
The American Psychiatric Association, founded in 1844, is the oldest medical association in the country. The APA is also the largest psychiatric association in the world with more than 40,400 physician members specializing in the diagnosis, treatment, prevention and research of mental illnesses. APA’s vision is to ensure access to quality psychiatric diagnosis and treatment. For more information, please visit www.psychiatry.org.